Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109305977B reveals a safer double-oxidation route for Tazobactam. Enhance supply chain stability and reduce manufacturing risks with this novel process.
Patent CN1671669A details a high-purity celecoxib synthesis route reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Patent CN101863830A reveals a high-yield synthesis of 2-amino-5-bromoisonicotinic acid (>60%), offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102718829B reveals high-yield TUDCA synthesis avoiding ion-exchange columns ensuring cost reduction and supply reliability for global pharmaceutical intermediates
Novel one-step synthesis of piperazinyl ionic liquid surfactants offering high purity and simplified processing for microemulsion applications.
Patent CN1043932A details a novel bromine-free route for hypolipidemic naphthalene derivatives, offering safer industrial scale-up and cost reduction in API manufacturing.
Patent CN115928110A enables high-concentration electrochemical dechlorination, offering reliable agrochemical intermediate suppliers a path to reduced energy consumption and superior purity.
Patent CN111254456B reveals green electrochemical oxidation for high-purity herbicide intermediates, offering substantial cost reduction and supply chain reliability.
Discover a novel dual-catalytic method for amide bond formation from carboxylic acids using blue light irradiation. Achieve cost reduction in pharmaceutical intermediate manufacturing with high atom economy.
Patent CN103254044A details a novel synthesis for high-purity phenanthrene derivatives, offering improved solubility and thermal stability for blue OLED applications.
Novel boronic acid protection method for high-purity ribose intermediate. Reduces steps and safety risks for scalable pharmaceutical manufacturing supply chains.
Patent CN112479860B reveals a novel Fe-catalyzed oxygen oxidation method for co-producing carboxylic acids and epsilon-caprolactone, offering significant cost reduction and supply chain reliability.
Novel purification process achieves greater than 99.5 percent purity. Reduces indole-3-carbaldehyde impurities significantly. Cost-effective scalable solution for pharmaceutical manufacturing.
Novel fructose-based FDCA synthesis reduces equipment corrosion and improves efficiency for bio-polymer supply chains globally.
Patent CN118812467B reveals co-oxidant method for FDCA. Reduces corrosion and improves efficiency for polymer manufacturing supply chains.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Novel synthesis process for chiral N-BOC-pyrrolidine-2-boric acid offers improved yield and purity. Reliable supply chain solution for pharmaceutical intermediate manufacturing needs.
Novel patent CN108129430A offers cost-effective Lifitegrast intermediate synthesis. High yield, scalable process for reliable pharmaceutical intermediate supply chains.
Patent CN1214021C details an efficient one-pot condensation route for isocoumarin derivatives, offering significant cost and supply chain advantages for API manufacturing.
Novel copper-catalyzed synthesis route offers high purity and yield for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.